The self-reported functional outcomes, clinical findings, and results of dental cast analysis before and after orthognathic surgery with surgically assisted rapid maxillary expansion (SARME) using a hybrid rapid maxillary expander (RME) were evaluated. Data were collected from 43 patients who underwent orthognathic surgery with SARME using a hybrid RME between 2001 and 2013. The patients were recruited during a follow-up clinical examination and were required to complete a questionnaire about their opinions and self-reported functional outcomes.
Introduction
Growth disturbances in the maxilla can lead to crowding of the teeth and a posterior crossbite, which can, in turn, cause nasal obstruction and oral breathing [1, 2] . Orthognathic surgery with surgically assisted rapid maxillary expansion (SARME) can improve facial-skeletal relationships and dental occlusion. Previous studies have shown that patients seek surgical orthodontic treatment to improve their facial and dental appearance and to correct functional occlusion discrepancies [3] [4] [5] . Although orthognathic surgery can yield functional and psychosocial improvements [6] , patients should be informed about the duration and side effects of these treatments [5, 7, 8] . SARME can correct transverse maxillomandibular discrepancies in skeletally mature patients from the age of 13 [9] [10] [11] . Both unilateral and bilateral transverse hypoplasia in skeletally mature patients can be corrected to provide dental arch space and to enlarge the maxillary apical base and palatal vault. The tongue is the most important source of pressure and is in direct contact with both the dental arches and the jaws; therefore, the size, posture, and function of the tongue are of utmost importance [12] . SARME creates more space for the tongue, thereby assisting the swallowing process and preventing relapse [6] .
Studies have shown that tooth-or bone-borne devices can be successfully used to expand a narrow maxilla by SARME [13, 14] . However, these expander devices also present with some disadvantages and complications [15, 16] . A few studies on hybrid rapid maxillary expansion (RME) devices have been published in the literature; nonetheless, the popularity of these devices is increasing owing to their relatively low rates of failure [17] and risk of tooth damage because the force is primarily applied to the bone [18] . Consequently, a hybrid RME device was developed at the Department of Oral and Maxillofacial Surgery, Karolinska Institute, Sweden. A modified hyrax appliance with both tooth and bone anchorage was used. The treatment effects of this appliance have not been evaluated so far.
According to a systematic review, it is not possible to establish an association among posterior crossbite, muscle pain, and disc displacement because equal number of studies both support and refute the associations [19] . Thus, studies regarding malocclusion and temporomandibular disorder (TMD) symptoms have not produced consistent results. Some studies report improvement of TMD symptoms after orthognathic surgery, whereas others show no improvement or worsening of the temporomandibular joint (TMJ) functions [20] [21] [22] . The other risks following orthognathic surgery include nerve injury with sensory disturbances in the soft tissue [23] .
It is also notable that these patients often present with severe malocclusions that frequently require a second surgery following SARME to correct jaw relation [15] . Additionally, uni-or bimaxillary surgery is conducted to correct the occlusion if required [24] .
This study aimed to examine the self-reported functional outcomes of SARME and the results of a dental cast analysis before and after orthognathic surgery using a hybrid RME device. The hypotheses tested in this study were as follows: 1) a normal occlusion with significant palatal expansion is achievable following orthognathic surgery with SARME using a hybrid RME device, and 2) patients are satisfied with the treatment results and the low prevalence of side effects.
Materials and Methods
Using a descriptive research methodology, this three-part study evaluated the outcomes of orthognathic surgery with SARME utilizing a hybrid device. In Part I, data were retrospectively collected from the medical records of the patients. In Part II, clinical findings were evaluated in correlation with the patients' self-reported functional outcomes. In Part III, palatal expansion was analyzed using the study casts. Figure 1 illustrates the design of the study.
The study participants included a cohort of consecutive patients (n = 43) aged between 13 and 50 years who underwent orthognathic surgery with SARME between 2001 and 2013 at the Department of Oral and Maxillofacial Surgery, Karolinska Institute, Sweden. The 43 patients were referred to the department by nine different orthodontic specialists from the Public Dental Services of Stockholm County Council or from private clinics. The patients were selected for surgery after meeting with oral and maxillofacial surgeons and orthodontists.
All patients were treated for narrow maxillas with posterior crossbite and prescribed a modified hyrax tooth-and bone-anchored expander device ( Fig. 2) , which was fabricated by dental technicians at the Karo-Journal of Oral Science, Vol. 62, No. 1, [107] [108] [109] [110] [111] 2020 Original article Satisfactory outcomes after orthognathic surgery with surgically assisted rapid maxillary expansion using a hybrid device linska Institute. This device has a low risk of tooth damage [18] and is tooth-and bone-anchored, which aids in the redirection of the force from the teeth to the bone. The minimum follow-up period in this study was 6 months. Patients with craniofacial anomalies and those who did not meet the previously mentioned inclusion criteria were excluded. The approval for this study was obtained from the ethical committee in Stockholm, Sweden (DNR: 2012/4:3).
All patients were preoperatively and clinically examined by the surgeon before treatment with SARME orthognathic surgery. At this time, the occlusion, TMJ status, and myofascial status were assessed and registered in the patients' records. SARME treatment was initiated with the installation of two 5-mm titanium bone screws (KLS Martin, Tuttlingen, Germany) into the palate, one on each side of the midline, close to the molars. Alginate impressions were taken, and the hybrid tooth-and bone-anchored RME device (see Fig. 2 ) was installed 1 to 2 days before surgery. Under general anesthesia, a Le Fort I osteotomy procedure was performed with an osteotomy in the midline of the maxilla without pterygomaxillary disjunction. The midline osteotomy enabled the expansion of the maxilla during the distraction phase, which was tested during the surgical procedure.
Approximately 1 week after surgery, the surgeon instructed the patient to set the expansion device to 0.25 to 1.00 mm per day. The distraction lasted for approximately 14 days or until the expansion was increased enough to visualize an open space between the central incisors (up to 15 mm). The distraction device remained attached to the teeth and palate for approximately 4 to 6 months (retention period) to maintain palatal expansion and to allow the bone to heal. During retention, the orthodontist bonded MBT.022 system braces (3M Unitek, St. Paul, MN, USA) to the teeth in the upper and lower jaws to achieve consistent dental arches. This treatment lasted for approximately 1 year. After the orthodontic treatment was completed, bonded retainers made of stainless-steel coaxial wires (MASEL Penta-One coaxial straight length 14."0215) were used as retention appliances in the upper and lower anterior regions to prevent relapse.
The patients were examined by an orthodontist and a surgeon 1 year after the SARME treatment to determine whether they needed a second surgery to correct the jaw relation. Uni-or bi-maxillary surgery was conducted to correct the teeth occlusion using Le Fort I osteotomy in the maxilla, intraoral vertical ramus osteotomy (IVRO), segmental ramus osteotomy (SRO), or bilateral sagittal split osteotomy (BSSO) in the mandible if required.
Part I: data collection from patient records
The patients' records were reviewed at the Department of Oral and Maxillofacial Surgery using the TakeCare digital medical record system (CompuGroup Medical). The preoperative data included gender, age, dental occlusion, and intra-and extra-oral conditions, whereas the postoperative data included the duration of orthognathic treatment, type of surgery or surgeries, and dental occlusion. All collected data were password-protected and coded before incorporation into a Microsoft Excel document.
Part II: clinical follow-up examination and the questionnaire
The patients (n = 43) were contacted by telephone to request for voluntary participation in the study; among them, 30 patients (69.8%; 12 women and 18 men) agreed to participate, whereas 13 (30.2%) declined to participate in the follow-up examination owing to relocation (n = 8; 61.5%) and lack of interest (n = 5; 38.5%; Fig. 1 ). A general dental practitioner who did not participate in the treatment planning or execution conducted all the clinical examinations and distributed the questionnaire.
The clinical follow-up included an evaluation of the occlusion and TMJ status, including myofacial muscles and sensory disturbances in the oral mucosa and lips. The sagittal, vertical, and transversal relations of the mandible were assessed for dental occlusion according to Angle's classification [W.R. Proffit et al, Contemporary Orthodontics, 5th ed., 204-214, Mosby Elsevier Inc. (ISBN 978-0-323-08317-1), 2012]. TMJ function was evaluated according to a simplified diagnostic criteria for TMD; by measuring the maximum opening capacity between the incisors to calculate the laterotrusion, mediotrusion, and protrusion in mm; and by assessing the presence of clicking or crepitation sounds from the joints. Unlimited, unassisted opening capacities of ≥35 mm were classified as normal. Normal, unlimited laterotrusion, mediotrusion, and protrusion were established as ≥7 mm. Muscle tenderness was measured by palpation on a scale of 0 to 3, with 0 indicating no pain, 1 representing mild pain, 2 indicating moderate pain, and 3 indicating severe pain [25] . The lips and gingiva were examined for changes in sensory perception (e.g., hypo-or hypersensitivity) using a simplified quantitative sensory pinprick test with a dental probe and toothbrush [26] . Each patient served as their own control, wherein untreated areas of the palatal and lingual gingiva with no incisions were used as references. The questionnaire comprised 10 questions regarding the patients' opinions about their treatment outcomes (TMJ status, aesthetic appearance, and sensory disturbances in the oral mucosa or lips). Alginate impressions of the jaws were taken at the follow-up examination for comparison with preoperative casts.
Part III: cast analysis
Twenty-nine preoperative casts were collected from the orthodontic clinics; the remaining preoperative casts were missing because the clinics did not save them after a period of 10 years. Postoperative dental casts (n = 29) were produced at follow-up examinations. Pre-and postoperative casts were used to analyze the palatal expansion and changes in dental occlusion. A vernier caliper device was used to measure intercanine and intermolar widths. Additionally, the palatal heights were measured (Fig.  3) . Subsequently, the casts were collected, produced, and analyzed by the same general dental practitioner who conducted the follow-up examinations.
Statistical analysis
All collected data were compiled and statistically analyzed using Microsoft Excel and the statistical program Statistica (TIBCO Software Inc., Palo Alto, CA, USA). The Shapiro-Wilk test was used to determine if the data were normally distributed. Differences in means were calculated using the t-test and Mann-Whitney U-test. The significance was set at P ≤ 0.05. Further evaluations of the dental occlusions were made after orthognathic treatment with SARME. Among the 43 patients, 31 (72.1%) continued to present with malocclusion that required a second surgery; 4 of the 31 patients (12.9%) did not cooperate or choose to proceed with a second surgery, whereas 27 patients (87.1%) agreed to undergo a second surgery. Furthermore, 13 (48.1%) of the 27 patients who agreed to undergo a second surgery received a Le Fort I osteotomy to adjust the maxilla; 3 (11.1%) received SRO, BSSO, or IVRO to adjust the mandible; and 11 (40.7%) underwent bimaxillary surgery. After treatment, 33 patients (76.7%) presented normal postoperative sagittal, vertical, and transversal relations of occlusion, whereas 10 (23.3%) presented malocclusion ( Fig. 4) .
Results

Results for part I: data collection
Results for part II: clinical follow-up examination and questionnaire Clinical Assessment
The mean follow-up time was 68 months (25-135 months). Among the 30 participants in Part II, 24 (80.0%) presented with Angle's Class I occlusion with an overbite of 1-3 mm and no transversal discrepancies, indicating that normal occlusion was achieved after orthognathic surgery with SARME, using a hybrid RME device. None of the patients presented impaired or reduced capacity of mandibular movement at follow-up. One patient (3.3%) reported pain on palpation of one joint, and two patients (6.7 %) experienced tenderness in both joints. Another patient (3.3%) complained of pain in the masseter and temporalis myofascial muscles on palpation. Nine patients (30.0%) presented with clicking sounds in the joint, whereas crepitations were not heard in any of the patients. As mentioned in the results of Part I, two patients (4.7%) showed preoperative myalgia with no signs of TMD at follow-up. Twenty patients (66.7%) subjected to surgery presented with visual scar tissue in the intraoral area. Eighteen patients (60.0%) experienced hyposensitivity in the vestibular maxillary oral mucosa, and four (13.3%) experienced hyposensitivity in the upper lip.
Questionnaire
Of the 30 patients who completed the questionnaire, 29 (96.7%) reported that they were satisfied with the orthognathic treatment with SARME using the hybrid RME device, and none regretted having undergone the treatment. Twenty-eight patients (93.3%) felt that they had received suf- Flow chart of orthognathic treatment with SARME. Among the 43 patients who received SARME treatment, 12 showed neutral occlusion, and 31 needed a second surgery due to malocclusion (2 declined the second surgery because they were satisfied with the treatment result, 1 declined because he or she was out of the country, and 1 did not cooperate). Of the 27 patients who received a second surgery, 21 showed neutral occlusion, and 6 continued to present with malocclusion. In total, 33 patients demonstrated neutral occlusion, whereas 10 patients continued to present with malocclusion after completing the treatment.
Fig. 3
Measurements of the pre-and postoperative cast models. (a) measurements of the pre-and postoperative cast models were performed using a sliding vernier caliper. Intermaxillary measurements were taken at two anterior and two posterior reference points. C denotes the intercanine width, the distance between the most prominent cervical points of the palatal ridge on the canines (two anterior reference points). M denotes the intermolar width, the distance between the most cervical points of the palatal fissure on the first molars (two posterior reference points). (b) palatal depth was measured as the distance from the mid-deepest part of the palate to the line connecting the left and right disto-lingual cusp tips of the upper first molars. ficient preoperative information. According to most of the patients, other preoperative difficulties (such as biting and chewing, dental position, facial appearance, speech, self-esteem) had improved after orthognathic surgery with SARME ( Fig. 5 ). Worsening of pain from TMJ was uncommon among the patients (6.7%, Fig. 5 ). Permanent upper lip sensation disturbance bothered 4 patients (13.3%), and 1 patient (3.3%) was dissatisfied with the treatment due to impaired sensation in the upper lip.
Results for part III: cast analyses
Preoperative casts confirmed the epidemiologic data and diagnoses in the patient records from Part I. The most common malocclusion was bilateral posterior crossbite (n = 18; 62.1%). Analyses of the preoperative and postoperative casts revealed that orthognathic surgery with SARME and the hybrid RME device improved transverse occlusion and teeth alignment. Significant improvements were achieved in intermaxillary distance (intercanine: P < 0.005; intermolar: P < 0.05 × 10 4 ) and palatal height (P < 0.05), as presented in Table 1 .
Discussion
The present study evaluated the self-reported functional outcomes of orthognathic surgery with SARME using a hybrid RME device in correlation with the clinical findings and dental cast analyses. Overall, the patients were satisfied with the results, which included improvements in both function and aesthetics. TMD symptoms following treatment were uncommon, and significant palatal expansion was achieved. According to the medical records, most patients achieved postoperative Angle's Class I molar relation after treatment completion. However, most of the patients needed a second surgery to correct the vertical height and further improve the occlusion, thus confirming the general notion that malocclusion often involves multiple diagnoses and additional treatments [15, 24] . There is no consensus in the literature regarding the type of distractor (tooth-borne or bone-borne) that should be used for SARME for the provision of optimal expansion and stability [9, [27] [28] [29] . However, hybrid devices might be a beneficial alternative, wherein the force is applied onto two points (tooth and bone) instead of one (tooth alone), thereby causing a parallel expansion of the palatal vault instead of just tipping the tooth. During the retention phase, the two-pointed surface maintains stability [16] . The present study confirms that a significant, sustained expansion of the maxilla and normal occlusion can be achieved using a hybrid RME device for orthognathic surgery with SARME.
In a recent systematic review, the frequency of intra-and postoperative complications following orthognathic surgery with SARME was low [30] . Based on the medical records in the current study, none of the patients experienced preoperative pain, clicking, or crepitations in the TMJ, although a few had preoperative myalgia. In a study by Østensjø et al. [31] , the prevalence of TMD was reported to be low in a group of healthy adolescents. At clinical follow-up in the present study, the patients with myalgia showed improvements in their symptoms, although some showed signs of arthralgia, myalgia, and clicking sounds from the TMJ. Thus, these findings cannot confirm whether orthognathic surgery improves or worsens TMJ function; however, the frequency of TMD symptoms was low [20] [21] [22] . Most patients indicated few complications (e.g., hyposensitivity in the oral mucosa and lips) at follow-up, which supports the findings by Philips et al. [23] . These results confirm the outcomes of a previously published systematic review by Starck-Jensen and colleagues [30] ; however, none of the included studies in the review assessed patient-reported outcome measures. Consequently, patient-reported outcome measures were evaluated in the present study, wherein most patients expressed satisfaction with the information received and did not regret undergoing the treatment. Furthermore, difficulties (such as biting and chewing, dental and facial appearance, speech, and self-reported pain from the TMJ) were improved following surgery. These findings are in line with those reported by Modig et al. [8] , wherein the overall attitude of the patients toward SARME was reported to be positive; additionally, the researchers believed that it is important to inform the patients about the upcoming treatment method in order to improve their motivation and cooperation.
Analyses of pre-and postoperative casts revealed significant expansion of the maxilla along with normal dental occlusion following treatment, which is consistent with the literature [30, 32] . In most patients, a second orthognathic surgery procedure was necessary to adjust the relationship between the jaws and to achieve a normal dental occlusion. However, some patients continued to present with malocclusion following a second surgery, indicating that some preoperative malocclusions are severe and difficult to treat. The frequency of postoperative malocclusion could indicate either relapse or suboptimal treatment results. One could speculate that the preoperative extraction of premolars to reduce the width of the maxilla could complicate maxillary expansion using the SARME technique.
Some confounders may have affected the results in this study. A control group was not included because the participants served as controls. The preoperative status in Part I was compared with the postoperative status in Part II. In addition, a previous, 3-year follow-up of both OME and SARME showed that the treatments remained stable in the patients when compared with a control group [33] . Hence, studies using a 6-month retention period, as in the present study, may report less relapse compared with those that use a 3-month stabilization period [34] . Nevertheless, further prospective, randomized studies investigating SARME treatment with the use of a hybrid RME device are warranted.
Based on the results of this study, crossbite was the most common indication for orthognathic treatment with SARME. The functional and Did SARME treatment alter complaints for... …the better? …the same? …the worse? …or it was not a problem to begin with? Fig. 5 Multiple-choice questionnaire about alteration of preoperative complaints due to orthognatic surgery with SARME using a hybrid device. Multiple-choice questionnaire about alteration of preoperative complaints (e.g., facial appearance, dental occlusion, temporomandibular disorders, speech, and self-esteem) due to surgery were evaluated. The discomforts of most patients were either not present from the start or had improved after orthognatic surgery with SARME using a hybrid device. Some patients observed no improvement as a result of the surgery, whereas five patients reported worsening of the preoperative speech difficulties and pain in the temporomandibular joint. 2 Pre-and postoperative palatal width and height were analyzed from cast models. Intermaxillary measurements were made. C denotes intercanine width, M denotes intermolar width, and PH denotes palatal depth. The palatal expansion was significantly different (t-test, P < 0.05).
self-perceived aesthetic aspects of the dentition were improved. The prevalence of postoperative TMD symptoms at follow-up was low. A low percentage of patients reported altered sensations in the lips, which is a common and expected side effect of the surgery. Significant expansion of the maxilla occurred in patients who underwent orthognathic surgery with SARME using a hybrid RME device. Most patients achieved a normal dental occlusion using the SARME technique in combination with a second orthognathic surgical procedure.
